DAEWOONG PHARMA
Develops and manufactures drugs, biologics, and active pharmaceutical ingredients.
069620 | KO
Overview
Corporate Details
- ISIN(s):
- KR7069620003
- LEI:
- Country:
- South Korea
- Address:
- 경기도 화성시 향남읍 제약공단4길 35-14, 화성시
- Sector:
- Manufacturing
Description
Daewoong Pharma is an R&D-centric pharmaceutical company specializing in the development, manufacturing, and commercialization of medical products. The company's portfolio encompasses prescription drugs, with a focus on gastrointestinal and endocrine therapies, alongside biologics, healthcare products, and active pharmaceutical ingredients (APIs). A core tenet of its business model is 'Open Collaboration,' actively seeking partnerships with academic and industry entities to foster innovation. Daewoong Pharma's research efforts are directed towards breakthrough therapies, utilizing advanced drug delivery technologies and expertise in biologics. The company also offers integrated formulation and manufacturing services, supporting partners from initial development to commercial production.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-04-29 00:00 |
영업(잠정)실적(공정공시)
|
Korean | 14.1 KB | ||
| 2024-04-16 00:00 |
투자판단관련주요경영사항
|
Korean | 12.4 KB | ||
| 2024-04-15 00:00 |
투자판단관련주요경영사항
|
Korean | 11.9 KB | ||
| 2024-04-09 00:00 |
투자설명서
|
Korean | 3.7 MB | ||
| 2024-04-09 00:00 |
증권발행실적보고서
|
Korean | 58.2 KB | ||
| 2024-04-08 00:00 |
투자판단관련주요경영사항
|
Korean | 17.8 KB | ||
| 2024-04-08 00:00 |
[발행조건확정]증권신고서(채무증권)
|
Korean | 21.4 KB | ||
| 2024-04-03 00:00 |
[기재정정]증권신고서(채무증권)
|
Korean | 4.3 MB | ||
| 2024-04-03 00:00 |
[발행조건확정]증권신고서(채무증권)
|
Korean | 551.5 KB | ||
| 2024-04-02 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 54.4 KB | ||
| 2024-03-28 00:00 |
정기주주총회결과
|
Korean | 30.0 KB | ||
| 2024-03-28 00:00 |
대표이사(대표집행임원)변경(안내공시)
|
Korean | 6.3 KB | ||
| 2024-03-28 00:00 |
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 11.1 KB | ||
| 2024-03-28 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 20.6 KB | ||
| 2024-03-28 00:00 |
최대주주등소유주식변동신고서
|
Korean | 30.8 KB |
Automate Your Workflow. Get a real-time feed of all DAEWOONG PHARMA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for DAEWOONG PHARMA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for DAEWOONG PHARMA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
